Inglés (pdf) · Articulo en XML; Referencias del artículo; Como citar este artículo El desarrollo normal de la hematopoyesis hepática fetal durante el segundo La intención de este artículo es determinar el papel de la fibronectina en la. Articulo. Español (pdf) · Articulo en XML; Referencias del artículo; Como citar este artículo; SciELO Analytics; Enviar articulo por email ARTÍCULO DE REVISIÓN La capacidad de la SCU para regenerar la hematopoyesis ha sido un hecho. ARTICULOS DE HEMATOPOYESIS PDF - No hay articulos citados Citado por Hematopoyesis hepática en el ratón sometido a mielosupresión por.
|Language:||English, French, Dutch|
|Genre:||Science & Research|
|ePub File Size:||26.86 MB|
|PDF File Size:||10.82 MB|
|Distribution:||Free* [*Registration Required]|
sus propios artículos en CORDIS; Notifier Recibir notificaciones por correo electrónico y guardar sus búsquedas . Hipoxia y hematopoyesis. La dosis umbral para detectar depresión en la hematopoyesis, durante la exposición ocupacional se ha estimado en un valor or a 0,4 Sv/año y la dosis. utilizando tensiómetros de cable o dinamómetros de presión manual. Adicionalmente .. médula ósea, y contridownloaden a la hematopoyesis, manteniéndose localmente y en . enviado los artículos que conforman esta tesis son los siguientes.
Myelomonocytic cells, during the first trimester of gestation, are located mostly in the mesenchymal tissue of the portal triads.
In the second trimester the distribution pattern is somewhat different. No main localization is seen in portal spaces, but scattered cells in liver parenchyma and sinusoids are visible. Lymphoid cells are present in small numbers in all stages.
These cells are partly scattered throughout the sinuses but, surprisingly, from 16 week onwards, a considerable number of lymphoid cells are also observed in the perivascular connective tissue in the portal triads and around the central veins, which is similar to the localization of myelopoiesis.
The availability of a broad range of monoclonal antibodies Mabs recognizing antigens present on cells of different haemopoietic lineages has extended the possibilities for an accurate description of the cells present in these separate lineages and their precursors during different stages of human embryonic and fetal development. CD34 antigen is a single chain transmembrane glycoprotein with a molecular weight of KD.
The CD34 protein is selectively expressed on human lymphoid and myeloid haematopoietic progenitor cells. The CD34 protein is also expressed on vascular endothelium. Our study gives insight into mechanisms of augmentation of hepatic hematopoiesis with fibronectin expression during the second trimester of development. Material and methods We studied 15 cases of hepatic fetal specimens in different stages of development 1st, 2nd, and 3rd trimester obtained after voluntary abortion due to leiomyoma five samples , to implantation of the fetus in the region of the internal os resulting in placenta previa six samples , and to endometriosis-adenomyosis four samples.
All cases were chosen from specific time of development 2nd month: five cases, 5th month: five cases and 8th month: five cases respectively.
The study was executed in harmony with the guidelines for the analysis of fetal cells and tissues and approved by the Ethics Committee of the General Hospital of Alexandroupolis.
Detection of the antigens in formalin-fixed tissue specimens required antigen-demasking protocols prior to application of antibodies. In most instances this was accomplished using high-pressure cooking 11 in 10 mM citrate buffer at pH 6. Specifically bound antibodies were made visible with the alkaline phospatase-anti-alkaline phosphatase APAAP technique 12 using FastRed as chromogen. The immunostained sections were examined with a X 40 objective and the distribution of fibronectin and NCL-END within the cell was recorded.
Every stained cell was scored as positive regardless of staining intensity. To count the number of cells with fibronectin and CD34 stainings, a 10 X 10 square calibrated grid was inserted into the eyepiece of an Olympus BX40 binocular microscope.
Five-to-ten fields were examined for each section, and at least 1, cells were scored, depending on cellularity.
The percentage of positive cells was recorded as the relevant indices. Hepatic portal triad stromal cells expressed fibronectin in 7 of 15 fetuses-cases during the first trimester Progenitor hematopoietic cells, stromal progenitor cells, and vascular endothelial cells expressed CD34 in 10 of 15 fetuses-cases during the first trimester Of 7 fetuse-cases with positive fibronectin expression during the first trimester, 5 were scored as grade I, and 2 as grade III.
Of 15 fetuse-cases with positive fibronectin expression during the second trimester, 4 were scored as grade I, 9 as grade II, and 2 as grade III. Immunohistochemical control for fibronectin is shown in figure 1; there is a strong reactivity with the stromal cells of the hepatic portal triads.
Of 8 fetuse-cases with positive fibronectin expression during the third trimester, 4 were scored as grade I, 2 as grade II, and 2 as grade III. Immunohistochemical control for CD34 is shown in figure 2: there is a strong reactivity with the progenitor hematopoietic stem cells, progenitor stromal cells and endothelial cells of the vessels of the hepatic portal triads.
Revista del Colegio de Microbiólogos y Químicos Clínicos de Costa Rica
Discussion Over the years, several models have been advanced proposing that haematopoietic lineage determination is driven extrinsically through growth factors, stroma or other external influences 13 , intrinsically as described in stochastic models 14,15 , or both 16, Within the haematopoietic microenvironment, early progenitors are maintained in specific compartmentalized niches, where they interact with other cell types and components of the extracellular matrix 18, The microenvironment has been reported to influence survival, proliferation, and differentiation 20, More recently, it has been suggested that the primary function of these extrinsic signals, including growth factors, is to support the survival and development of committed cells, whereas lineage commitment can be attributed to cell intrinsic mechanisms 14,15,17, Overall, it appears that the regulation of haematopoiesis is the result of multiple processes involving cell-cell and cell-extracellular matrix interactions, the action of specific growth factors and other cytokines, as well as intrinsic modulators of haematopoietic development.
In most cells, adhesion is an essential process in the control of growth and differentiation and, although hematopoietic progenitor cells can grow in suspension and therefore can bypass this requirement, they have a close association with their stromal extracellular matrix which, under physiological conditions, may regulate interactions with locally available growth factors.
Blood cell formation is controlled by a complex set of events, including interactions between ECM and hematopoietic cells Multiple cell types interact within a confined space in hematopoietic organs to deliver and receive critical signals for proliferation and differentiation.
Yokota et al. Therefore, FN seemed to promote colony formation of both committed and uncommitted progenitors, and these effects of FN were seen on a wider stage of differentiation than that reported by Weinstein et al. Several studies have shown that ligation of FN to integrins stimulate a variety of signaling events, including tyrosine phosphorylation, cytoplasmic alkalization, calcium influx, accumulation of cytoskeletal molecules at sites of cell adhesion, and altered gene expression Attachment of epithelial and endothelial cells to ECM is essential for their survival both in vitro and in vivo because they undergo apoptosis by the inhibition of these interactions In addition, several lines of evidence suggest that signal transduction events through integrin ligand engagement are involved in the suppression of apoptosis in anchored cells.
For example, attachment of epithelium to ECM via integrins regulated expression of interleukin 1 beta IL-1b converting enzyme, a protein associated with apoptosis Apoptosis of detached endothelial cells was suppressed by the addition of sodium vanadate, a protein tyrosine phosphatase inhibitor Moreover, injection of an anti-ppFAK antibody into rounded fibroblasts resulted in the rapid onset of apoptosis.
It is also known that ppFAK directly associates with b subunit of integrins, and its tyrosine phosphorylation and kinase activity are upregulated by the binding of FN to integrins Further analysis will be necessary to reveal the signal transduction pathway and structural basis of FN for promoting cell survival and growth.
All types of hemopoietic cells derive from a small pool of immature uncommitted progenitor cells. During the past few decades the phenotype of the hemopoietic progenitors has been analyzed in detail. This antigen is expressed on almost all types of hemopoietic progenitors. However, CD34 is also expressed on stromal cell progenitors and even on vascular endothelium.
Fibronectin, one of the components of ECM molecules, plays an important role in the regulation of hematopoietic differentiation. The mechanism s of action of fibronectin on hematopoietic stem cell and microenvironment remain to be determined; however, fibronectin may possibly act by increasing binding of hematopoietic cells to stromal cells and by increasing the utilization of hematopoietic growth factors by the stem cells cooperating with other ECM molecules.
Our results imply that the expression of fibronectin in higher amounts during the second trimester of gestation provides evidence that this specific extracellular matrix glycoprotein induces the hemopoietic progenitor cell proliferation and differentiation in the fetal liver.
Mosher DF. Physiology of fibronectin. Annu Rev Med ; Ruoslahti E. Fibronectin and its receptors. Annu Rev Biochem ; Provisional matrix: The molecular and cellular biology of wound repair.
hematopoyesis articulo bctII
In: Clark RAF, editor. New York: Plenum Press. Schwarzbauer JE. Fibronectin: From gene to protein. Curr Opin Cell Biol ; 3: Humphries MJ.
Fibronectin and cancer: rationales for the use of antiadhesives in cancer treatment. Semin Cancer Biol ; 4 5 : Martin MA, Bhatia M. Nakata T, Ogama M. Hematopoietic colony forming cells in umbilical cord blood with extensive capability to generate mono and multipotential hematopoietic progenitors.
J Clin Invest. N Engl J Med. Acta Bioquim Clin Latinoamer. Rubinstein P. Cord blood banking for clinical trasplantation. Bone Marrow Transplant.
Gluckman E. History of cord blood trasplantation.
There was a problem providing the content you requested
Bone Marrow Trasplant. Unrelated donor hematopoietic cell trasplantation:marrow or umbilical cord blood? Ten Years of cord blood transplantation: from bench to bedside.
Br J Haematol. Current status of umbilical cord blood hematopoietic stem cell transplantation Exp Hematol. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Fruchtman S. Stem cell trasplantation. Mt Sinai J Med.
Clinical applications of stem cell transfusion from cord and rationales for cord blood banking. Cord blood banking and trasplant in Europe. Eurocor Vox Sang. Representation of Hispanics in the National Donor Marrow program. Alternative haematopoietic stem cell sources for transplantation: place of umbilical cord blood. Br J Haematol Oct; 2 Bojanic I, Golubic CB.
Umbilical cord blood as source of stem cell. Acta Med Croatica. Rev Cub Hematol Hemoter.
Prenatal identification of potential donors for umbilical cord blood transplantation for Fanconi. Radiosensitivity in Fanconi anemia application to conditioning regimen for bone marrow trasplantation.
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Comparison of outcomes unrelated of bone marrow and cord blood transplants in children with acute leukemia. Trasplants of umbilical cord blood or marrow from unrelated donor in adults with acute leukemia.
Outcomes after transplantation of cord blood or bone marrow from unrelated donors with leukemia. Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant. Rebulla P. Cord blood banking. Kusminsky G. Cord blood banking: proving cord blood banking for a nation. Umbilical cord blood banking: public good or private benefit?
Med J Aust. Donors selection and retieval of units in an umbilical cord blood bank. Med Clin Barc.Reduced- intensity conditioning and umbilical cord blood transplantation in adults.
Annu Rev Med ; Immunohistochemical control for CD34 is shown in figure 2: there is a strong reactivity with the progenitor hematopoietic stem cells, progenitor stromal cells and endothelial cells of the vessels of the hepatic portal triads. Cord blood banking. Blood ; Gould D, Kessler D.
Dissecting the marrow microenvironment. Nature ;